Search
Close this search box.
Search
Close this search box.

Press Releases

Bitget’s Blockchain4Youth Celebrates Two Years of Youth-Driven Innovation

VICTORIA, Seychelles, May 26, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, is excited to celebrate the 2nd Anniversary of Blockchain4Youth. With over 8,000 participants globally and more than 3,000 certificates issued, the program continues to empower the next generation with the knowledge and tools needed

Read More

SAR 423 Billion in Foreign Investments: Saudi Arabia Launches Offshore Securities Business License

RIYADH, Saudi Arabia, May 26, 2025 (GLOBE NEWSWIRE) — Over the past decade, the Saudi Capital Market Authority (CMA) has methodically advanced the Kingdom’s capital market reforms, gradually opening its financial markets to international investors. This transformation has attracted substantial global institutional interest, with foreign holdings reaching approximately SAR 423

Read More

Bitget Lists World Liberty Financial’s USD1 (USD1) Token for Spot Trading

Bitget Lists World Liberty Financial’s USD1 (USD1) Token for Spot Trading Bitget Lists World Liberty Financial’s USD1 (USD1) Token for Spot Trading VICTORIA, Seychelles, May 26, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of USD1, adding it to spot trading. World Liberty

Read More

CERE DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Action – CERE

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024,

Read More

ATNM DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 27 Deadline in Securities Class Action – ATNM

NEW YORK, May 25, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the “Class Period”), of the important May 27, 2025 lead plaintiff deadline.

Read More